Can a Patient in Intensive Care be Visited by His or Her Pet?
NCT ID: NCT06121050
Last Updated: 2025-07-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
30 participants
INTERVENTIONAL
2025-07-03
2029-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
As a result, improving patient experience has become a priority in the ICU, and particular attention is being paid to the need to recreate a familiar environment.
Animal-mediated interventions have been developed for a number of patients over many years. These strategies are widely used with elderly patients, and patients with cognitive or psychiatric disorders, for whom the literature shows benefits on anxiety, mood or objective signs of stress.
In the vast majority of experiments carried out to date, the animals (mainly dogs) were prepared and educated for contact with patients, and their handlers trained in this activity, rather like guide dogs. Visiting a care facility with a patient's own pet is rarely described. It may run up against obstacles related to the animal's behavior or infectious risks, but it is nevertheless authorized in many establishments.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pilot Feasibility Study of a Pragmatic Mixed-Methods Randomized Controlled Trial on a Follow-Up Bundle of Care for ICU Survivors and Caregivers
NCT06681649
ICU Follow-up After Prolonged Intensive Care Stay
NCT04186468
Impact of Frailty and ICU-AW on Post-ICU Fatigue Self-reported
NCT05984069
Gut-Brain-Axis/Lung-Brain-Axis and Mental Ill Health in Critical Illness
NCT05580367
Long-term Follow up in Survivors of Critical Illness
NCT04608994
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pet visit
Intensive care patients visited by their pets for 20 minutes
Pet visit
Intensive care patients visited by their pets for 20 minutes
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pet visit
Intensive care patients visited by their pets for 20 minutes
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with no or no longer hemodynamic or respiratory failure, or undergoing rehabilitation, after resolution of the acute phase or at the end of life.
* Patients affiliated to or entitled under a social security scheme.
* Patient who has given written informed consent to participate in the study.
Exclusion Criteria
* Mechanical or amine ventilation or extrarenal purification.
* Tracheostomy.
* Immunosuppression.
* Carriage of multi-resistant bacteria.
* Behavioral or consciousness disorders.
* Pregnancy.
* Skin wounds, extensive burns exceeding 15% of body surface area, external fixator.
* Guardianship or trusteeship.
* Workload incompatible with the visit
* Patient unable to speak French.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Saint Etienne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Cindy POKRANDT
Role: PRINCIPAL_INVESTIGATOR
CHU SAINT-ETIENNE
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier Ardèche Nord
Annonay, , France
Centre Hospitalier de Saint-Etienne
Saint-Etienne, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023-A01439-36
Identifier Type: OTHER
Identifier Source: secondary_id
21PH263
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.